Skip to main content
Erschienen in: Journal of General Internal Medicine 12/2020

17.06.2020 | Original Research

Readmission Rates for Chronic Obstructive Pulmonary Disease Under the Hospital Readmissions Reduction Program: an Interrupted Time Series Analysis

verfasst von: Russell G. Buhr, MD, PhD, Nicholas J. Jackson, PhD, MPH, Gerald F. Kominski, PhD, Steven M. Dubinett, MD, Carol M. Mangione, MD, MSPH, Michael K. Ong, MD, PhD

Erschienen in: Journal of General Internal Medicine | Ausgabe 12/2020

Einloggen, um Zugang zu erhalten

Abstract

Background

Hospital readmission rates decreased for myocardial infarction (AMI), heart failure (CHF), and pneumonia with implementation of the first phase of the Hospital Readmissions Reduction Program (HRRP). It is not established whether readmissions fell for chronic obstructive pulmonary disease (COPD), an HRRP condition added in 2014.

Objective

We sought to determine whether HRRP penalties influenced COPD readmissions among Medicare, Medicaid, or privately insured patients.

Design

We analyzed a retrospective cohort, evaluating readmissions across implementation periods for HRRP penalties (“pre-HRRP” January 2010–April 2011, “implementation” May 2011–September 2012, “partial penalty” October 2012–September 2014, and “full penalty” October 2014–December 2016).

Patients

We assessed discharged patients ≥ 40 years old with COPD versus those with HRRP Phase 1 conditions (AMI, CHF, and pneumonia) or non-HRRP residual diagnoses in the Nationwide Readmissions Database.

Interventions

HRRP was announced and implemented during this period, forming a natural experiment.

Measurements

We calculated differences-in-differences (DID) for 30-day COPD versus HRRP Phase 1 and non-HRRP readmissions.

Key Results

COPD discharges for 1.2 million Medicare enrollees were compared with 22 million non-HRRP and 3.4 million HRRP Phase 1 discharges. COPD readmissions decreased from 19 to 17% over the study. This reduction was significantly greater than non-HRRP conditions (DID − 0.41%), but not HRRP Phase 1 (DID + 0.02%). A parallel trend was observed in the privately insured, with significant reduction compared with non-HRRP (DID − 0.83%), but not HRRP Phase 1 conditions (DID − 0.45%). Non-significant reductions occurred in Medicaid (DID − 0.52% vs. non-HRRP and − 0.21% vs. Phase 1 conditions).

Conclusions

In Medicare, HRRP implementation was associated with reductions in COPD readmissions compared with non-HRRP controls but not versus other HRRP conditions. Parallel findings were observed in commercial insurance, but not in Medicaid. Condition-specific penalties may not reduce readmissions further than existing HRRP trends.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
Zurück zum Zitat Patient Protection and Affordable Care Act, Pub. L. No. 111-148, Stat. 124 Stat. 119 (March 23, 2010). Patient Protection and Affordable Care Act, Pub. L. No. 111-148, Stat. 124 Stat. 119 (March 23, 2010).
3.
Zurück zum Zitat Medicare Program; Proposed Changes to the Hospital Inpatient Prospective Payment Systems for Acute Care Hospitals and the Long-Term Care Hospital Prospective Payment System and Fiscal Year 2012 Rates, 76 (2011). Medicare Program; Proposed Changes to the Hospital Inpatient Prospective Payment Systems for Acute Care Hospitals and the Long-Term Care Hospital Prospective Payment System and Fiscal Year 2012 Rates, 76 (2011).
4.
Zurück zum Zitat Medicare Program; Hospital Inpatient Prospective Payment Systems for Acute Care Hospitals and the Long-Term Care Hospital Prospective Payment System and FY 2012 Rates; Hospitals’ FTE Resident Caps for Graduate Medical Education Payment, 76 (2011). Medicare Program; Hospital Inpatient Prospective Payment Systems for Acute Care Hospitals and the Long-Term Care Hospital Prospective Payment System and FY 2012 Rates; Hospitals’ FTE Resident Caps for Graduate Medical Education Payment, 76 (2011).
5.
Zurück zum Zitat Medicare Program; Hospital Inpatient Prospective Payment Systems for Acute Care Hospitals and the Long-Term Care Hospital Prospective Payment System and Proposed Fiscal Year 2014 Rates; Quality Reporting Requirements for Specific Providers; Hospital Conditions of Participation, 78 (2013). Medicare Program; Hospital Inpatient Prospective Payment Systems for Acute Care Hospitals and the Long-Term Care Hospital Prospective Payment System and Proposed Fiscal Year 2014 Rates; Quality Reporting Requirements for Specific Providers; Hospital Conditions of Participation, 78 (2013).
6.
Zurück zum Zitat Medicare Program; Hospital Inpatient Prospective Payment Systems for Acute Care Hospitals and the Long-Term Care Hospital Prospective Payment System and Fiscal Year 2014 Rates; Quality Reporting Requirements for Specific Providers; Hospital Conditions of Participation; Payment Policies Related to Patient Status, 78 (2013). Medicare Program; Hospital Inpatient Prospective Payment Systems for Acute Care Hospitals and the Long-Term Care Hospital Prospective Payment System and Fiscal Year 2014 Rates; Quality Reporting Requirements for Specific Providers; Hospital Conditions of Participation; Payment Policies Related to Patient Status, 78 (2013).
12.
Zurück zum Zitat Fingar K, Washington R. Trends in Hospital Readmissions for Four High-Volume Conditions, 2009-2013: Statistical Brief #196. Rockville (MD): Agency for Healthcare Research and Quality (US); 2015. Fingar K, Washington R. Trends in Hospital Readmissions for Four High-Volume Conditions, 2009-2013: Statistical Brief #196. Rockville (MD): Agency for Healthcare Research and Quality (US); 2015.
18.
Zurück zum Zitat Yale New Haven Health Services Corporation/Center for Outcomes Research & Evaluation. 2016 Condition-Specific Measures Updates and Specifications Report Hospital-Level 30-Day Risk-Standardized Readmission Measures. Baltimore, MD: Centers for Medicare & Medicaid Services; 2016. Yale New Haven Health Services Corporation/Center for Outcomes Research & Evaluation. 2016 Condition-Specific Measures Updates and Specifications Report Hospital-Level 30-Day Risk-Standardized Readmission Measures. Baltimore, MD: Centers for Medicare & Medicaid Services; 2016.
19.
Zurück zum Zitat Yale New Haven Health Services Corporation/Center for Outcomes Research & Evaluation. 2017 Condition-Specific Measures Updates and Specifications Report Hospital-Level 30-Day Risk-Standardized Readmission Measures. Baltimore, MD: Centers for Medicare & Medicaid Services; 2017. Yale New Haven Health Services Corporation/Center for Outcomes Research & Evaluation. 2017 Condition-Specific Measures Updates and Specifications Report Hospital-Level 30-Day Risk-Standardized Readmission Measures. Baltimore, MD: Centers for Medicare & Medicaid Services; 2017.
20.
Zurück zum Zitat Stagg V. ELIXHAUSER: Stata module to calculate Elixhauser index of comorbidity. Boston College Department of Economics: Statistical Software Components; 2015. Stagg V. ELIXHAUSER: Stata module to calculate Elixhauser index of comorbidity. Boston College Department of Economics: Statistical Software Components; 2015.
23.
Zurück zum Zitat Joynt KE, Figueroa JE, Oray J, Jha AK. Opinions on the Hospital Readmission Reduction Program: Results of a National Survey of Hospital Leaders. Am J Manag Care. 2016;22(8):e287-94.PubMedPubMedCentral Joynt KE, Figueroa JE, Oray J, Jha AK. Opinions on the Hospital Readmission Reduction Program: Results of a National Survey of Hospital Leaders. Am J Manag Care. 2016;22(8):e287-94.PubMedPubMedCentral
35.
Zurück zum Zitat Buhr RG, Jackson NJ, Kominski GF, Dubinett SM, Mangione CM, Ong MK. Factors associated with differential readmission diagnoses following acute exacerbations of chronic obstructive pulmonary disease. J Hosp Med. 2020;15. https://doi.org/10.12788/jhm.3367 Buhr RG, Jackson NJ, Kominski GF, Dubinett SM, Mangione CM, Ong MK. Factors associated with differential readmission diagnoses following acute exacerbations of chronic obstructive pulmonary disease. J Hosp Med. 2020;15. https://​doi.​org/​10.​12788/​jhm.​3367
42.
Metadaten
Titel
Readmission Rates for Chronic Obstructive Pulmonary Disease Under the Hospital Readmissions Reduction Program: an Interrupted Time Series Analysis
verfasst von
Russell G. Buhr, MD, PhD
Nicholas J. Jackson, PhD, MPH
Gerald F. Kominski, PhD
Steven M. Dubinett, MD
Carol M. Mangione, MD, MSPH
Michael K. Ong, MD, PhD
Publikationsdatum
17.06.2020
Verlag
Springer International Publishing
Erschienen in
Journal of General Internal Medicine / Ausgabe 12/2020
Print ISSN: 0884-8734
Elektronische ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-020-05958-0

Weitere Artikel der Ausgabe 12/2020

Journal of General Internal Medicine 12/2020 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.